The present invention relates to the field of personalized 5 medicine, and in particular to molecular signatures allowing the identification of individuals with cancer as being susceptible to respond to a treatment
Sonveaux, P., & De Miranda Capeloa, T. I. (2021). Molecular signature for assessing the responsiveness of cancer to mitochondria-targeted antioxidants. https://hdl.handle.net/2078.5/31176